{"id":"W3080835754","doi":"10.1200/jco.2009.27.15_suppl.5064","title":"Phase Ib dose finding trial of intravenous panobinostat with docetaxel in patients with castration-resistant prostate cancer (CRPC)","year":2009,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Histone Deacetylase Inhibitors Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":8,"is_retracted":false,"has_abstract":true,"ca_institutions":"Juravinski Cancer Centre; BC Cancer Agency","funders":"","keywords":"Medicine; Panobinostat; Docetaxel; Prostate cancer; Internal medicine; Neutropenia; Cohort; Febrile neutropenia; Clinical endpoint; Adverse effect; Oncology; Cancer; Chemotherapy; Clinical trial","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001901502,0.002037507,0.002137254,0.0006672677,0.0005763032,0.00130497,0.001199827,0.001828926,0.004002249],"category_scores_gemma":[0.001311745,0.0007999532,0.001170227,0.0007168821,0.001444929,0.0008271537,0.0004946589,0.004158593,0.0009973358],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001547748,"about_ca_system_score_gemma":0.002605421,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002065778,"about_ca_topic_score_gemma":0.004394555,"domain_scores_codex":[0.9994509,0.0002955837,0.00002619302,0.00007918386,0.00004390763,0.0001042256],"domain_scores_gemma":[0.9989497,0.0001776734,0.0002141603,0.00007424398,0.00005281926,0.0005314704],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.829764,0.08813618,0.004650841,0.0005795009,0.000727615,0.0002165077,0.0002397274,0.003270373,0.01471766,0.0002604215,0.003212437,0.05422478],"study_design_scores_gemma":[0.6609066,0.3317819,0.003760323,0.00002503535,0.0001603646,0.0001143177,0.00002903692,0.0008919953,0.001050402,0.0001227767,0.001139364,0.00001806663],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9907758,0.001397323,0.0004668277,0.0006792333,0.0001760809,0.003488122,0.0009372686,0.000122827,0.001956573],"genre_scores_gemma":[0.9883806,0.001112527,0.001500619,0.001048986,0.0002246954,0.003131535,0.002257574,0.00002549176,0.002317999],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004002249,"threshold_uncertainty_score":0.01338881,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05242496451691746,"score_gpt":0.4402851169811156,"score_spread":0.3878601524641981,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}